Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
2019-2023 Europe Cancer Diagnostics Market Analysis: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Latest Tumor Markers, Volume and Sales Segment Forecasts, Technology and Instrumentation
US$ 19,700.00
... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
January 2019
820 pages
2019-2023 Diagnostic Imaging: A Market in Transition--X-ray, Ultrasound, MRI, CT, Nuclear Medicine, PET, PACS
US$ 3,850.00
This new worldwide strategic overview of the diagnostic imaging market includes the following:- Estimates of the market size and growth.- Sales forecasts by ... etc.- System service and support.- Internally developed and acquired diagnostic imaging and related technologies, including X-ray, ultrasound, MRI, CT, ...
January 2019
185 pages
Molecular Diagnostics: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Molecular Diagnostics in US$ Thousand by the following Applications: Infectious Disease Testing, Blood Screening, ... 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
December 2018
570 pages
Genetic Testing: Market Research Report
US$ 5,600.00
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The report provides separate comprehensive analytics for the US, ... 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary ...
December 2018
316 pages
Clinical Laboratory Services: Market Research Report
US$ 5,600.00
... analyzes the worldwide markets for Clinical Laboratory Services in US$ Million by the following Segments: Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories. The report provides ...
December 2018
470 pages
Blood Cancer Therapeutics: Global Markets to 2023
US$ 1,375.00
... , reimbursement and patents. It analyzes prevailing blood cancer treatment guidelines in different geographic regions. The scope of the blood cancer therapeutic market is restricted to three disease areas: leukemia ...
December 2018
174 pages
2019-2023 Europe Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Market: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 19,700.00
... Current and Emerging Products Analysis of current and emerging molecular blood typing, grouping and infectious disease NAT screening assays. Review ... test. Strategic Recommendations New product development opportunities for molecular blood typing, grouping and infectious disease NAT assays and instrumentation ...
December 2018
630 pages
